Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

(2019) Susan Swindells et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings

(2018) Karl T Johnson et al.   CLINICAL INFECTIOUS DISEASES

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

(2017) Anani Badje et al.   Lancet Global Health

The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis

(2016) Hannah Alsdurf et al.   LANCET INFECTIOUS DISEASES

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

(2016) Rein M. G. J. Houben et al.   PLOS MEDICINE

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models

(2016) Rein M G J Houben et al.   Lancet Global Health

Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

(2015) Anthony T. Podany et al.   CLINICAL INFECTIOUS DISEASES

Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection

(2015) Molebogeng X Rangaka et al.   LANCET

A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control

(2014) Gavin J. Churchyard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial

(2013) Betina Durovni et al.   LANCET INFECTIOUS DISEASES

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

(2011) Taraz Samandari et al.   LANCET